{'fraction_non_alphanumeric': 0.012139605462822459, 'fraction_numerical': 0.006069802731411229, 'mean_word_length': 5.285714285714286, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Fibroblast growth factor (FGF) 5 can inhibit the growth of hepatocellular cell line

We completed the quantitative profiles of FGFs and FGFRs in hepatocellular carcinomas (HCC) and hepatoblastomas compared with normal liver cells in the previous study. Several FGFs including FGF5 and its functional receptors were hightly expressed in hepatocellular carcinoma cell lines even though the FGFs are not checked from normal liver cDNAs. As FGF5 are known to have the mitogenic and cell survival activity in the cancer, we studied to check the inhibition effect for hepatocellular carcinogenesis by interfering FGF5 activity with its siRNAs in the HCC cell lines.